- Home
- MGNX vs SHIP Comparison
MGNX vs SHIP Comparison
Compare MGNX & SHIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGNX
- SHIP
- Stock Information
- Founded
- MGNX 2000
- SHIP 2008
- Country
- MGNX United States
- SHIP Greece
- Employees
- MGNX N/A
- SHIP N/A
- Industry
- MGNX Biotechnology: Pharmaceutical Preparations
- SHIP Marine Transportation
- Sector
- MGNX Health Care
- SHIP Consumer Discretionary
- Exchange
- MGNX Nasdaq
- SHIP Nasdaq
- Market Cap
- MGNX 151.9M
- SHIP 141.8M
- IPO Year
- MGNX 2013
- SHIP 2007
- Fundamental
- Price
- MGNX $2.20
- SHIP $7.33
- Analyst Decision
- MGNX Hold
- SHIP Strong Buy
- Analyst Count
- MGNX 10
- SHIP 3
- Target Price
- MGNX $7.17
- SHIP $12.00
- AVG Volume (30 Days)
- MGNX 551.0K
- SHIP 243.9K
- Earning Date
- MGNX 05-08-2025
- SHIP 03-06-2025
- Dividend Yield
- MGNX N/A
- SHIP 10.37%
- EPS Growth
- MGNX N/A
- SHIP 1660.03
- EPS
- MGNX N/A
- SHIP 2.11
- Revenue
- MGNX $141,329,000.00
- SHIP $167,459,000.00
- Revenue This Year
- MGNX $177.84
- SHIP N/A
- Revenue Next Year
- MGNX N/A
- SHIP $10.86
- P/E Ratio
- MGNX N/A
- SHIP $3.48
- Revenue Growth
- MGNX 16.68
- SHIP 51.91
- 52 Week Low
- MGNX $2.15
- SHIP $6.55
- 52 Week High
- MGNX $19.54
- SHIP $13.19
- Technical
- Relative Strength Index (RSI)
- MGNX 35.93
- SHIP 59.40
- Support Level
- MGNX $2.16
- SHIP $6.82
- Resistance Level
- MGNX $2.49
- SHIP $7.41
- Average True Range (ATR)
- MGNX 0.17
- SHIP 0.26
- MACD
- MGNX -0.00
- SHIP 0.04
- Stochastic Oscillator
- MGNX 7.87
- SHIP 61.24
About MGNX MacroGenics Inc.
Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. It's a pipeline of product candidates designed to target either various tumor-associated antigens or immune checkpoint molecules. Its pipeline MGC018 (B7-H3), Lorigerlimab (PD-1 x CTLA-4), Tebotelimab (PD-1 x LAG-3), MGD024 (CD123 x CD3), IMGC936 (ADAM9), Enoblituzumab (anti-B7-H3), Retifanlimab (PD-1), and MGD014 (HIV x CD3).
About SHIP Seanergy Maritime Holdings Corp.
Seanergy Maritime Holdings Corp is an international shipping company that provides marine dry bulk transportation services through the ownership and operation of dry bulk vessels. It generates a majority of its revenue from the vessels. The company fleet of vessels includes Fellowship, Championship, Partnership, Knightship, Lordship, Gloriuship, Leadership, Geniuship, Premiership, and Squireship among others.